Rapid-acting IM ziprasidone in a psychiatric emergency service: a naturalistic study
Authors:
- Andrew FrancisAFAndrew Francis
- 30 April 2005
- journal article
- research article
- Published by Elsevier in General Hospital Psychiatry
- Vol. 27 (2) , 140-144
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Ziprasidone and haloperidol in the treatment of acute exacerbation of schizophrenia and schizoaffective disorder: comparison of intramuscular and oral formulations in a 6-week, randomized, blinded-assessment studyPsychopharmacology, 2005
- Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophreniaInternational Journal of Neuropsychopharmacology, 2003
- A Review of the Safety and Efficacy of Droperidol for the Rapid Sedation of Severely Agitated and Violent PatientsThe Journal of Clinical Psychiatry, 2003
- A Double-blind, Placebo-Controlled Dose-Response Comparison of Intramuscular Olanzapine and Haloperidol in the Treatment of Acute Agitation in SchizophreniaArchives of General Psychiatry, 2002
- Validation of the behavioural activity rating scale (BARS)™: a novel measure of activity in agitated patientsJournal of Psychiatric Research, 2002
- Pharmacological Treatment of Psychotic AgitationCNS Drugs, 2002
- Double-Blind, Placebo-Controlled Comparison of Intramuscular Olanzapine and Intramuscular Haloperidol in the Treatment of Acute Agitation in SchizophreniaAmerican Journal of Psychiatry, 2001
- Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trialPsychopharmacology, 2001
- Intramuscular Ziprasidone, 2 mg Versus 10 mg, in the Short-Term Management of Agitated Psychotic PatientsThe Journal of Clinical Psychiatry, 2001
- Intramuscular Ziprasidone Compared With Intramuscular Haloperidol in the Treatment of Acute PsychosisThe Journal of Clinical Psychiatry, 2000